IP Library › Assignment 037566/0014
Patent Assignment
Reel/Frame 037566/0014

Change of Name

Recorded: 2016-01-20 Pages: 5
Assignor
ENVIVO PHARMACEUTICALS, INC.
Executed: 2014-04-02
Assignee
FORUM PHARMACEUTICALS, INC.
225 SECOND AVENUE, WALTHAM, MASSACHUSETTS, 02451
Covered Property (1)
Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
Patent: 9,550,767 →
Application: 15/002,163 →
Publication: US 2016/0137638
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 20, 2016
From: OLIVER-SHAFFER, PATRICIA; SHAPIRO, GIDEON; CHESWORTH, RICHARD
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 037538/0209 →
Assignment of Assignor's Interest Jan 20, 2016
From: KISHIDA, MUNEKI; ISHIGE, TAKAYUKI
To: MITSUBISHI TANABE PHARMA CORPORATION
Reel/Frame 037538/0255 →
Assignment of Assignor's Interest Jan 20, 2016
From: MITSUBISHI TANABE PHARMA CORPORATION
To: ENVIVO PHARMACEUTICALS, INC.
Reel/Frame 037538/0290 →
Security Interest Jul 5, 2016
From: FORUM PHARMACEUTICALS INC.
To: FMR LLC
Reel/Frame 039254/0828 →